Cochrane Abstracts
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"High Dose Rate Versus Low Dose Rate Intracavity Brachytherapy for Locally Advanced Uterine Cervix Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439392/all/High_dose_rate_versus_low_dose_rate_intracavity_brachytherapy_for_locally_advanced_uterine_cervix_cancer.
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439392/all/High_dose_rate_versus_low_dose_rate_intracavity_brachytherapy_for_locally_advanced_uterine_cervix_cancer. Accessed March 17, 2025.
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439392/all/High_dose_rate_versus_low_dose_rate_intracavity_brachytherapy_for_locally_advanced_uterine_cervix_cancer
High Dose Rate Versus Low Dose Rate Intracavity Brachytherapy for Locally Advanced Uterine Cervix Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439392/all/High_dose_rate_versus_low_dose_rate_intracavity_brachytherapy_for_locally_advanced_uterine_cervix_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
ID - 439392
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439392/all/High_dose_rate_versus_low_dose_rate_intracavity_brachytherapy_for_locally_advanced_uterine_cervix_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
